Bayer (ETR: BAYN), the German multinational, has announced a strategic collaboration to globally distribute Hurdle’s saliva-based Chronomics biological age tests through electronic channels. Based in the UK, Hurdle specializes in diagnostics, and its at-home biomarker tests utilize epigenetic markers to measure biological age, positioning them as precision health solutions aimed at promoting healthy aging.
This partnership will be managed by Bayer’s newly established precision health product development segment within its consumer health division, underscoring the company’s commitment to advancing innovative health solutions in the growing wellness market.- Flcube.com
